Renata Mikołajczak Selected Research

Solitary Pulmonary Nodule

9/2006	Differential diagnosis of solitary pulmonary nodules based on 99mTc-EDDA/HYNIC-TOC scintigraphy: the effect of tumour size on the optimal method of image assessment.
2/2006	Short communication: Semiquantitative assessment of 99mTc-EDDA/HYNIC-TOC scintigraphy in differentiation of solitary pulmonary nodules--a complementary role to visual analysis.
1/2006	Comparative analysis of 99mTc-depreotide and 99mTc-EDDA/HYNIC-TOC thorax scintigrams acquired for the purpose of differential diagnosis of solitary pulmonary nodules.
10/2004	Efficacy of 99mTc-EDDA/HYNIC-TOC scintigraphy in differential diagnosis of solitary pulmonary nodules.
7/2004	99mTc-EDDA/HYNIC-TOC scintigraphy in the differential diagnosis of solitary pulmonary nodules.
1/2004	A visual and semi-quantitative assessment of (99m)Tc-EDDA/HYNIC-TOC scintigraphy in differentiation of solitary pulmonary nodules.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Renata Mikołajczak Research Topics

Disease

14	Neoplasms (Cancer) 10/2021 - 01/2005
8	Thyroid Neoplasms (Thyroid Cancer) 01/2021 - 07/2006
6	Neoplasm Metastasis (Metastasis) 03/2021 - 10/2003
6	Solitary Pulmonary Nodule 09/2006 - 01/2004
5	Prostatic Neoplasms (Prostate Cancer) 05/2021 - 10/2003
4	Neuroendocrine Tumors (Neuroendocrine Tumor) 03/2021 - 01/2005
3	Insulinoma 01/2016 - 04/2013
2	Lymphoma (Lymphomas) 10/2020 - 01/2008
2	Infections 01/2017 - 01/2004
2	Inflammation (Inflammations) 01/2017 - 01/2004
2	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2015 - 01/2008
1	medullary Thyroid cancer 11/2021
1	Breast Neoplasms (Breast Cancer) 10/2021
1	Primary Myelofibrosis (Myelosclerosis) 05/2021
1	Hypoglycemia (Reactive Hypoglycemia) 01/2016
1	Munchausen Syndrome (Munchhausen Syndrome) 01/2016
1	Nesidioblastosis (Nesidioblastosis of Pancreas) 01/2016
1	Liver Neoplasms (Liver Cancer) 08/2014
1	Disease Progression 08/2014
1	Heart Diseases (Heart Disease) 04/2012
1	Glioma (Gliomas) 01/2004
1	Cicatrix (Scar) 01/2004
1	Carcinoid Tumor (Carcinoid) 10/2003
1	Leiomyosarcoma 10/2003
1	Melanoma (Melanoma, Malignant) 10/2003
1	Pancreatic Neoplasms (Pancreatic Cancer) 10/2003

Drug/Important Bio-Agent (IBA)

12	EDDA (NiEDDA)IBA 01/2016 - 01/2004
10	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 01/2020 - 07/2004
7	Radioisotopes (Radionuclides)IBA 10/2021 - 01/2006
6	RadiopharmaceuticalsIBA 11/2021 - 01/2004
6	Somatostatin Receptors (Somatostatin Receptor)IBA 03/2021 - 01/2005
4	LigandsIBA 03/2021 - 10/2007
3	1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA 01/2021 - 08/2009
3	Cholecystokinin B ReceptorIBA 01/2021 - 10/2007
3	Peptide Receptors (Peptide Receptor)IBA 01/2020 - 10/2007
3	Exenatide (Byetta)FDA Link 01/2016 - 04/2013
2	BombesinIBA 01/2021 - 08/2009
2	Technetium (Technetium 99m)IBA 01/2017 - 01/2004
2	minigastrinIBA 01/2017 - 03/2016
2	Chromogranin AIBA 01/2016 - 10/2007
2	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2016 - 04/2013
2	Octreotide (Sandostatin)FDA LinkGeneric 01/2016 - 01/2006
2	GastrinsIBA 01/2016 - 10/2007
2	Peptides (Polypeptides)IBA 08/2009 - 10/2007
2	Calcitonin (Calcitonin, Eel)FDA LinkGeneric 10/2007 - 09/2006
2	technetium Tc 99m hydrazinonicotinyl-Tyr(3)-octreotideIBA 09/2006 - 07/2006
1	diglycolic acidIBA 10/2021
1	Bombesin Receptors (Bombesin Receptor)IBA 10/2021
1	aniline (aniline hydrobromide)IBA 10/2021
1	EnzymesIBA 05/2021
1	Biological ProductsIBA 03/2021
1	yttrium(III)- 1,4,7,10- tetraazacyclotetradecane- N,N',N'',N'''- tetraacetic acidIBA 01/2021
1	Chelating AgentsIBA 10/2020
1	177Lu-DOTA-rituximabIBA 10/2020
1	DOTA-NHSIBA 10/2020
1	Cholecystokinin Receptors (Cholecystokinin Receptor)IBA 04/2018
1	exametazime FDA Link 01/2017
1	Cholecystokinin (Pancreozymin)IBA 03/2016
1	Insulin (Novolin)FDA Link 01/2016
1	C-PeptideIBA 01/2016
1	Biomarkers (Surrogate Marker)IBA 01/2016
1	Glucagon (Glukagon)FDA Link 01/2016
1	indoleacetic acid (indole acetic acid)IBA 01/2016
1	Rituximab (Mabthera)FDA Link 01/2015
1	Serum AlbuminIBA 08/2014
1	Glucagon-Like Peptide-1 ReceptorIBA 04/2013
1	Gastrin-Releasing PeptideIBA 08/2009
1	Glu-OctagastrinIBA 10/2007
1	3-Tyr-octreotideIBA 10/2007
1	99mTc-octreotideIBA 01/2006
1	TurpentineIBA 01/2004
1	Tyrosine (L-Tyrosine)FDA Link 01/2004
1	hippuryl-glycyl-glycine (HIGG)IBA 01/2004
1	Proteins (Proteins, Gene)FDA Link 01/2004
1	Adrenocorticotropic Hormone (ACTH)FDA Link 10/2003

Therapy/Procedure

12	Therapeutics 10/2021 - 01/2004
4	Radiotherapy 01/2017 - 01/2004
3	Precision Medicine 01/2021 - 04/2018
1	Castration 05/2021
1	Radioimmunotherapy 10/2020
1	Molecular Targeted Therapy 06/2017
1	Palliative Care (Palliative Therapy) 08/2014
1	Microspheres (Microsphere) 08/2014
1	Neoadjuvant Therapy 01/2012
1	Aftercare (After-Treatment) 01/2008
1	Injections 01/2004